Table 3.
Rheumatoid Arthritis-Related Information with Univariate Analysis and Resulting p values for Differences Between Activation Levels
| Patient Activation Level | Level 1 | Level 2 | Level 3 | Level 4 | Total | p value |
|---|---|---|---|---|---|---|
| Seropositivity (%) | ||||||
| Positive | 9 (11.0) | 15 (18.3) | 32 (39.0) | 26 (31.7) | 82 (68.9) | 0.399 |
| Erythrocyte sedimentation Rate (standard deviation) | 32 (28) | 39 (30) | 31 (30) | 27 (23) | 31 (28) | 0.339 |
| Disease duration, years | 11.4 (6.6) | 13.4 (8.8) | 14.9 (7.1) | 12.8 (8.3) | 13.5 (7.8) | 0.198 |
| Disease duration (%) | ||||||
| Early (≤2 years) | 2 (33.3) | 1 (16.7) | 1 (16.7) | 2 (33.3) | 6 (3.1) | 0.466 |
| Established (>2 years) | 24 (12.7) | 26 (13.8) | 69 (36.5) | 70 (37.0) | 189 (96.9) | |
| Disease activity score - erythrocyte sedimentation rate (%) | ||||||
| DAS28-ESR median (IQR) | 1.21 (0.00–2.46) | 2.41 (0.00–3.18) | 0.68 (0.00–3.03) | 0.87 (0.00–2.64) | 1.14 (0.00–2.46) | 0.822 |
| Remission to mild | 19 (15.1) | 18 (14.3) | 42 (33.3) | 47 (37.3) | 126 (69.6) | 0.271 |
| Moderate to severe | 4 (7.3) | 9 (16.4) | 25 (45.5) | 17 (30.9) | 55 (30.4) | |
| csDMARDs | 11 (11.1) | 17 (17.2) | 33 (33.3) | 38 (38.4) | 99 (50.3) | 0.346 |
| TNFi, non-TNFi, small molecule agents | 8 (9.4) | 16 (18.8) | 33 (38.8) | 28 (32.9) | 85 (43.1) | 0.126 |
| Corticosteroids (%) | 1 (3.4) | 5 (17.2) | 12 (41.4) | 11 (37.9) | 29 (14.7) | 0.361 |
| NSAIDs (%) | 0 (0.0) | 3 (27.3) | 4 (36.4) | 4 (36.4) | 11 (5.6) | 0.367 |
Note: *Significance level according to p < 0.05.